共 138 条
[1]
Chew HK(2006)Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 458-464
[2]
Wun T(1999)Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy Risk Analysis Using Medicare Claims Data Medicine (Baltimore) 78 285-291
[3]
Harvey D(2007)Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 632-634
[4]
Zhou H(2000)A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy Thromb Haemost 84 805-810
[5]
White RH(2009)Working group of the SOR, French National Federation of Cancer C. 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group Ann Oncol: Off J Eur Soc Med Oncol/ESMO 20 1459-1471
[6]
Levitan N(2010)2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group Crit Rev Oncol Hematol 73 31-46
[7]
Dowlati A(2013)International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer J Thromb Haemost 11 56-70
[8]
Remick SC(2012)Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer Oncologist 17 419-427
[9]
Tahsildar HI(2011)Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II Thromb Haemost 105 962-967
[10]
Sivinski LD(2010)Bleeding complications associated with anticoagulant therapy in patients with cancer Thromb Res 125 S58-S61